1-5 of 5
Justine Dell'Aringa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Circulating Tumor DNA (ctDNA) As an Early Outcome Predictor in Patients (pts) with Second-Line (2L) Large B-Cell Lymphoma (LBCL) after Lisocabtagene Maraleucel (liso-cel) Versus Standard of Care (SOC) Treatment (tx) from the Phase 3, Randomized Transform Study

Lara Stepan, Sahar Ansari, Abood Okal, Justine Dell'Aringa, Ethan G. Thompson, Alessandro Crotta, Victor A. Chow, Jeremy S. Abramson, Manali Kamdar, Scott R. Solomon, Patrick B. Johnston, Bertram Glass, Pim Mutsaers, Jon E. Arnason, Stephan Mielke, Mazyar Shadman, Francisco Hernandez-Ilizaliturri, Koji Izutsu, Veronika Bachanova, Sami Ibrahimi, Jacob Chabon, David Kurtz, Ash A. Alizadeh, Leanne Peiser
Journal: Blood
Blood (2024) 144 (Supplement 1): 72.
https://doi.org/10.1182/blood-2024-199813
Published: 2024
Journal Articles

Circulating Tumor DNA Dynamics as Early Outcome Predictors for Lisocabtagene Maraleucel as Second-Line Therapy for Large B-Cell Lymphoma from the Phase 3 TRANSFORM Study

Lara Stepan, Sahar Ansari, Abood Okal, Justine Dell'Aringa, Ethan Thompson, Alessandro Crotta, Victor A Chow, Jeremy S. Abramson, Manali Kamdar, Jacob J. Chabon, Gregory Hogan, David M. Kurtz, Ash A. Alizadeh, Leanne Peiser
Journal: Blood
Blood (2023) 142 (Supplement 1): 225.
https://doi.org/10.1182/blood-2023-181007
Published: 2023
Journal Articles

Durvalumab (Anti PD-L1) As Monotherapy or in Combination Therapy for Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL): A Subgroup Analysis from the Phase 1/2 Fusion NHL-001 Global Multicenter Trial

Carla Casulo, Armando Santoro, Kiyoshi Ando, Steven Le Gouill, Jia Ruan, MD PhD, John Radford, Luca Arcaini, Antonello Pinto, Reda Bouabdallah, Koji Izutsu, MD PhD, Simon Rule, Javier Munoz, MD, Marie-Laure Casadebaig, Brian Fox, Nils Rettby, Justine Dell'Aringa, Richard Delarue, Kathryn Newhall, Myron Czuczman, Guillaume Cartron
Journal: Blood
Blood (2019) 134 (Supplement_1): 5320.
https://doi.org/10.1182/blood-2019-124102
Published: 2019
Journal Articles

Comprehensive Immune Profiling from Peripheral Blood and Bone Marrow in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma Patients Reflects Differences in Immune Subsets and Activation Status

Greg E. Pietz, BS, MS, Mark Tometsko, BSc, Wilbert B. Copeland, PhD, Elizabeth Whalen, PhD, Frank Schmitz, MD PhD, Ethan G. Thompson, PhD, Amit Agarwal, MD PhD, Teresa Foy, PhD, Lauren Buchholz, BS, Vitalina Komashko, PhD, Justine Dell'Aringa, BSc, Brian A. Fox, PhD, Kathryn Newhall, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3161.
https://doi.org/10.1182/blood-2018-99-115107
Published: 2018
Journal Articles

Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML

George S. Laszlo, Chelsea J. Gudgeon, Kimberly H. Harrington, Justine Dell’Aringa, Kathryn J. Newhall, Gary D. Means, Angus M. Sinclair, Roman Kischel, Stanley R. Frankel, Roland B. Walter
Journal: Blood
Blood (2014) 123 (4): 554–561.
https://doi.org/10.1182/blood-2013-09-527044
Published: 2014
Includes: Supplemental data